featured
Effect of Lorcaserin on Prevention and Remission of Type 2 Diabetes in Overweight and Obese Patients
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effect of Lorcaserin on Prevention and Remission of Type 2 Diabetes in Overweight and Obese Patients (CAMELLIA-TIMI 61): A Randomised, Placebo-Controlled Trial
Lancet 2018 Oct 03;[EPub Ahead of Print], EA Bohula, BM Scirica, SE Inzucchi, DK McGuire, AC Keech, SR Smith, E Kanevsky, SA Murphy, LA Leiter, JP Dwyer, R Corbalan, C Hamm, L Kaplan, JC Nicolau, TO Ophuis, KK Ray, M Ruda, J Spinar, T Patel, W Miao, C Perdomo, B Francis, S Dhadda, MP Bonaca, CT Ruff, MS Sabatine, SD WiviottFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.